Key facts
- Notable investors include University of Oxford.
- Status: Out of Business.
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Oxomics
- ·The full record, as it builds
Funding rounds
No funding rounds for Oxomics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Oxomics
Developer of a diagnostics technology designed to treat cancer. The company's technology offers a diagnostic test that helps in detecting tumors with a low false-positive rate and offers cutting-edge signal detection with the power of AI, helping physicians in the early detection of cancer.
- Sector
- Healthcare
- HQ
- Oxford, United Kingdom
- Founded
- 2019
- Employees
- 3
- Website
- oxomics.com/
- Ownership
- Out of Business
Oxomics doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Oxomics shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Oxomics in its N-PORT filings yet. We sweep new filings monthly.